The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges

Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges

June 15, 2017 • By Ruth Jessen Hickman, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Although non-steroidal anti-inflammatory drugs are generally safe, it is still worth checking for interactions, because so many complex drugs are used in HIV. When in doubt, get help from infectious disease specialists, pharmacists or other resources. The members of the Department of Pharmacology at the University of Liverpool maintain a freely available drug–drug interaction resource that can be used to help safely prescribe drugs to HIV-positive patients.22

You Might Also Like
  • HIV Infection: What Rheumatologists Need to Know
  • Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients
  • Prospects for Treating Patients with Arthritis in African Countries with Few Rheumatologists
Explore This Issue
June 2017
Also By This Author
  • How to Manage, Treat Anemia of Inflammation in Patients with Rheumatic Disease

What Drugs Can Be Used Safely for Rheumatic Conditions in Patients Who Have HIV?

Many rheumatic conditions in patients with HIV can be managed with non-steroidal anti-inflammatory drugs or other therapies that are generally safe in these patients. However, a small proportion of patients receiving cART will also need disease-modifying drugs or biologics to control their disease.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although published evidence is limited, it appears that these therapies can generally be safely prescribed if testing reveals that that CD4+ counts are above 200 cells/mm3 and the HIV viral activity is completely suppressed.4 Dr. Calabrese notes, “Certain drugs like hydroxychloroquine and sulfasalazine we feel pretty safe about, but antimetabolites like methotrexate or luflonomide or biologic drugs—this is serious business and people need to do this with interprofessional collaboration. Any immunosuppressive in an HIV-infected patient has to be done with active collaboration of the HIV-treating physician under all circumstances.” He adds, “A patient who is not well controlled for HIV will not be a good candidate for many therapies.”

This is an area of ongoing research. Dr. Calabrese is a co-author of recently published study examining the biologic drug TNF-α for refractory rheumatoid arthritis in patients who are also HIV positive. When carefully selected and monitored, these patients do not appear at greater risk of infection compared to patients without HIV.26

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Key Points for Rheumatologists

1) Maintain a low threshold for HIV testing in the rheumatology office. Currently in the U.S., there are no specific recommendations on testing for HIV in the context of rheumatic care. However, the general public health recommendation is that healthcare providers should test everyone between the ages of 13 and 64 at least once for HIV, with repeated screenings recommended for persons at high risk of HIV. Patients should be informed so they can opt out if they wish, but pretest counseling is not necessary.27

Dr. Calabrese points out, “This is not observed by most physicians, even primary care physicians. When we are starting immunosuppressive therapy and particularly biologics, we routinely screen people for hepatitis B and hepatitis C. It is very simple to [add HIV]. Ask, ‘Have you ever been tested for HIV infection? We should do this at this time if it makes sense.’”

Pages: 1 2 3 4 5 6 7 8 9 | Single Page

Filed Under: Conditions, Practice Management Tagged With: arthralgias, challenge, combination antiretroviral therapy, Diagnosis, drug interaction, HIV, Myopathy, patient care, Rheumatic Disease, rheumatologist, rheumatology, treamentIssue: June 2017

You Might Also Like:
  • HIV Infection: What Rheumatologists Need to Know
  • Experts Discuss Rheumatologists’ Role in Treating Depression, Anxiety and Psychological Comorbidities in Their Patients
  • Prospects for Treating Patients with Arthritis in African Countries with Few Rheumatologists
  • Sjögren’s Syndrome in Kids: Diagnostic Challenges & Treatment Options

About Ruth Jessen Hickman, MD

Ruth Jessen Hickman, MD, was born and raised in eastern Kentucky, where she first cultivated her love of literature, writing and personal narratives. She attended Kenyon college, where she received a Bachelor of Arts in philosophy, summa cum laude. She worked with individuals with psychiatric conditions and later in a neuroscience lab at the University of Illinois, Chicago, before graduating from Indiana University Medical School in 2011. Instead of pursuing clinical medicine, Ruth opted to build on her strength of clearly explaining medical topics though a career as a freelance medical writer, writing both for lay people and for health professionals. She writes across the biomedical sciences, but holds strong interests in rheumatology, neurology, autoimmune diseases, genetics, and the intersection of broader social, cultural and emotional contexts with biomedical topics. Ruth now lives in Bloomington, Ind., with her husband, son and cat. She can be contacted via her website at ruthjessenhickman.com.

View more by this author»

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.